100 related articles for article (PubMed ID: 15974897)
1. Lessons from Darwin: evolutionary biology's implications for Alzheimer's disease research and patient care.
Becker RE
Curr Alzheimer Res; 2005 Jul; 2(3):319-26. PubMed ID: 15974897
[TBL] [Abstract][Full Text] [Related]
2. Lessons from Darwin: 21st century designs for clinical trials.
Becker RE
Curr Alzheimer Res; 2007 Sep; 4(4):458-67. PubMed ID: 17908050
[TBL] [Abstract][Full Text] [Related]
3. Treating Alzheimer's disease: do clinical trial methods produce unnecessary practitioner dilemmas?
Becker RE
Am J Alzheimers Dis Other Demen; 2006; 21(2):81-4. PubMed ID: 16634462
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's disease drug development: old problems require new priorities.
Becker RE; Greig NH
CNS Neurol Disord Drug Targets; 2008 Dec; 7(6):499-511. PubMed ID: 19128207
[TBL] [Abstract][Full Text] [Related]
5. Design of comprehensive Alzheimer's disease centers to address unmet national needs.
Trojanowski JQ; Arnold SE; Karlawish JH; Brunden K; Cary M; Davatzikos C; Detre J; Gaulton G; Grossman M; Hurtig H; Jedrziewski K; McCluskey L; Naylor M; Polsky D; Schellenberg GD; Siderowf A; Shaw LM; Van Deerlin V; Wang LS; Werner R; Xie SX; Lee VM
Alzheimers Dement; 2010 Mar; 6(2):150-5. PubMed ID: 20298979
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
Sinclair P; Kable A; Levett-Jones T
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
[TBL] [Abstract][Full Text] [Related]
7. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Centers of excellence in Alzheimer's disease: it is time to better integrate patient care and clinical research to improve the prevention and treatment of Alzheimer's disease.
Doody RS
Alzheimers Dement; 2009 Mar; 5(2):133-6. PubMed ID: 19328443
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease drug development in 2008 and beyond: problems and opportunities.
Becker RE; Greig NH
Curr Alzheimer Res; 2008 Aug; 5(4):346-57. PubMed ID: 18690832
[TBL] [Abstract][Full Text] [Related]
9. Application of clinical trial simulation to compare proof-of-concept study designs for drugs with a slow onset of effect; an example in Alzheimer's disease.
Lockwood P; Ewy W; Hermann D; Holford N
Pharm Res; 2006 Sep; 23(9):2050-9. PubMed ID: 16906456
[TBL] [Abstract][Full Text] [Related]
10. [Controlled randomized clinical trials].
Jaillon P
Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
[TBL] [Abstract][Full Text] [Related]
11. Clinical trials in Alzheimer's disease. A report from the Medical Research Council Alzheimer's Disease Clinical Trials Committee.
Swash M; Brooks DN; Day NE; Frith CD; Levy R; Warlow CP
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):178-81. PubMed ID: 1843446
[TBL] [Abstract][Full Text] [Related]
12. The project data sphere initiative: accelerating cancer research by sharing data.
Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
[TBL] [Abstract][Full Text] [Related]
13. Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Innovations in care that advance Alzheimer's disease drug development.
Foster NL; Andersen TC; Zamrini EY
Alzheimers Dement; 2009 Mar; 5(2):159-62. PubMed ID: 19328451
[TBL] [Abstract][Full Text] [Related]
14. Development of a unified clinical trial database for Alzheimer's disease.
Neville J; Kopko S; Broadbent S; Avilés E; Stafford R; Solinsky CM; Bain LJ; Cisneroz M; Romero K; Stephenson D;
Alzheimers Dement; 2015 Oct; 11(10):1212-21. PubMed ID: 25676387
[TBL] [Abstract][Full Text] [Related]
15. The evaluation of disease modifying therapies in Alzheimer's disease: a regulatory viewpoint.
Mani RB
Stat Med; 2004 Jan; 23(2):305-14. PubMed ID: 14716731
[TBL] [Abstract][Full Text] [Related]
16. Diagnostic misconceptions? A closer look at clinical research on Alzheimer's disease.
Kutschenko LK
J Med Ethics; 2012 Jan; 38(1):57-9. PubMed ID: 21873309
[TBL] [Abstract][Full Text] [Related]
17. Clinical research designs for emerging treatments for Alzheimer disease: moving beyond placebo-controlled trials.
Knopman D; Kahn J; Miles S
Arch Neurol; 1998 Nov; 55(11):1425-9. PubMed ID: 9823826
[TBL] [Abstract][Full Text] [Related]
18. Rivastigmine for Alzheimer's disease: Canadian interpretation of intermediate outcome measures and cost implications.
Baladi JF; Bailey PA; Black S; Bouchard RW; Farcnik KD; Gauthier S; Kertesz A; Mohr E; Robillard A
Clin Ther; 2000 Dec; 22(12):1549-61. PubMed ID: 11192146
[TBL] [Abstract][Full Text] [Related]
19. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
